Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2014-05-20 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Credit Suisse – Convertible Bond Conference
Investor Presentation Classification · 99% confidence The document is titled "Health Care Worldwide" and specifically mentions a "Credit Suisse – Convertible Bond Conference" presentation dated May 20, 2014. It contains an agenda, a safe harbor statement, and detailed slides covering company overview, financial results (sales, EBIT, net income), business segments (Fresenius Medical Care, Fresenius Kabi), and outlook. This structure—a presentation deck with financial highlights and strategic commentary delivered at an investor event—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS).
2014-05-20 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is a "Voting Rights Announcement" transmitted via DGAP, referencing German Securities Trading Act (WpHG) sections (sec. 25 WpHG). It details the acquisition/disposal of voting rights by COMMERZBANK AKTIENGESELLSCHAFT, crossing a 5% threshold on 14.05.2014. This content directly matches the definition of Director's Dealing (DIRS) or, more broadly, a notification of changes in significant share ownership. Since the document specifically details the crossing of a major shareholding threshold (5%) by an external entity, the most precise classification among the provided options is Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is more specific than RNS.
2014-05-19 English
Barclays - High Yield Bond and Syndicated Loan Conference
Investor Presentation Classification · 98% confidence The document text is structured as a presentation, indicated by the title '# Health Care Worldwide' and the explicit mention of the event: 'Barclays – High Yield Bond and Syndicated Loan Conference May 13, 2014 – Phoenix'. It contains an agenda, a safe harbor statement, and detailed slides covering company overview, business segments (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios), and financial results for Q1/2014 and FY2013. This format, which is a detailed presentation intended for investors/analysts at a conference, strongly aligns with the definition of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement (RPA/RNS) as the document content is extensive (over 50,000 characters total, though truncated here).
2014-05-13 English
Q1 Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for the Fresenius Group for the 1st Quarter of 2014. It contains comprehensive financial statements (Consolidated statement of income, cash flows, etc.), segment reporting, and a detailed management report. It is not an announcement (RPA) or a simple earnings release (ER) because it provides full financial tables and notes. Therefore, it is classified as an Interim/Quarterly Report. Q1 2014
2014-05-09 German
Factsheet Q1 2014
Fund Information / Factsheet Classification · 98% confidence The document is titled "# Factsheet Q1 / 2014" and contains detailed key performance indicators (KPIs) for the first quarter of 2014, including revenue, EBIT, balance sheet figures, segment breakdowns, stock information, and a financial calendar. This structure, presenting summarized financial and operational data for a specific short period (Q1), strongly indicates a Fund Information / Factsheet document, which is defined as a brief summary of key facts and financials. It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), nor is it merely an announcement of a report (RPA).
2014-05-06 German
Q1 2014 - Präsentation
Call Transcript Classification · 98% confidence The document text explicitly states "Conference Call – Q1/14 Results" and is dated May 6, 2014. It contains detailed financial tables for Q1/14, segment breakdowns, business updates, and outlooks, which are characteristic of an earnings-related event. The presence of a 'Safe Harbor Statement' and the structure strongly suggest this is the material used for an earnings conference call. Since the content is the detailed discussion and data surrounding the results, it fits the definition of a Call Transcript (CT) better than a brief Earnings Release (ER). The document length (over 53,000 characters) confirms it is substantial, ruling out RPA/RNS based on the 'MENU VS MEAL' rule.
2014-05-06 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.